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Abstract
Background: The decline of proteasomal activity is known to be associated with the age-related disorders but the early
events involved in this process are not apparent. To address this, we investigated the early-age-related (pediatric vs. adult)
mechanisms that augment immunopathogenesis of sepsis and acute lung injury.
Methodology/Principal Findings: The 3-weeks (pediatric) and 6-months (adult) old C57BL/6 mice were selected as the
study groups. Mice were subjected to 1620 cecal ligation and puncture (CLP) mediated sepsis or intratracheal Psuedomonas
aeruginosa (Pa)-LPS induced acute lung injury (ALI).We observed a significant increase in basal levels of pro-inflammatory
cytokine, IL-6 and neutrophil activity marker, myeloperoxidase (MPO) in the adult mice compared to the pediatric indicating
the age-related constitutive increase in inflammatory response. Next, we found that age-related decrease in PSMB6
(proteasomal subunit) expression in adult mice results in accumulation of ubiquitinated proteins that triggers the unfolded
protein response (UPR). We identified that Pa-LPS induced activation of UPR modifier, p97/VCP (valosin-containing protein)
in the adult mice lungs correlates with increase in Pa-LPS induced NFkB levels. Moreover, we observed a constitutive
increase in p-eIF2a indicating a protective ER stress response to accumulation of ubiquitinated-proteins. We used MG-132
treatment of HBE cells as an in vitro model to standardize the efficacy of salubrinal (inhibitor of eIF2a de-phosphorylation) in
controlling the accumulation of ubiquitinated proteins and the NFkB levels. Finally, we evaluated the therapeutic efficacy of
salubrinal to correct proteostasis-imbalance in the adult mice based on its ability to control CLP induced IL-6 secretion or
recruitment of pro-inflammatory cells.
Conclusions/Significance: Our data demonstrate the critical role of early-age-related proteostasis-imbalance as a novel
mechanism that augments the NFkB mediated inflammation in sepsis and ALI. Moreover, our data suggest the therapeutic
efficacy of salubrinal in restraining NFkB mediated inflammation in the adult or older subjects.
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Introduction
Protein homeostasis is regulated by complex cellular processes
collectively termed as ‘proteostasis’, which includes protein
synthesis, folding, trafficking, disaggregation and degradation
[1]. One of the most crucial regulatory components of the
proteostasis machinery is the ubiquitin proteasome system (UPS)
[2]. The main function of the UPS is to degrade unwanted- or
misfolded/damaged- proteins in the cell by protease mediated
degradation [3]. Several other functions of this system are now
well documented, most importantly, the regulation of important
cellular signaling pathways like NFkB activation [4], cell cycle [5]
and response to environmental and cellular stress [6,7]. It also
plays a very crucial role in the innate and adaptive immune
response, by regulating antigen processing and presentation to the
T cells [8]. The importance of UPS in pathogenesis of chronic
diseases is evident from its critical role in several debilitating
pathological conditions which are the outcome of proteostasis-
imbalance [9]. An increase in proteasome activity is associated
with sepsis and cancer, where it leads to muscle wasting and
inflammation [10], tumor cell survival and metastasis [9]. In
contrast, diminished proteasome activity has been related to
chronic obstructive pulmonary disease (COPD), cardiac dysfunc-
tion, cataract, neurodegenerative and autoimmune diseases and
aging [9,11,12]. One can easily visualize that most of these
pathological conditions are aggravated with advancing age. In
fact, COPD, which was thought to be the outcome of long term
cigarette smoking, is also described as the disease of accelerated
lung aging [11].
One can describe the aging process as a lifelong molecular
damage (e.g. accumulation of misfolded proteins) that is
aggravated by an age-related decrease in the proteostatic
machinery [1], probably at an early phase of aging [13]. The
failure of organ or cell maintenance/repair results from the
integrated action among genes, environment, and intrinsic defects
of the organism that is provoked by constitutive early-age-related
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tory milieu that can exacerbate the existing damage, so that
inflammatory and anti-inflammatory factors can play a part in
shaping the outcomes of the aging process [14]. The age-related
changes result in accumulation of ubiquitinated, oxidized and
misfolded proteins [15,16,17] that leads to induction of ER stress
[18], unfolded protein response (UPR) and inflammation [19,20].
The accumulation of abnormal or misfolded protein aggregates
(aggresomes) is linked to various neurodegenerative disorders that
have a higher occurrence with advancing age [21,22].
The primary mechanism of misfolded protein degradation is the
endoplasmic reticulum associated degradation (ERAD) [23,24].
The UPR modifier, p97/VCP (valosin-containing protein) [25] is
known to be associated with key regulatory components of the
ERAD pathway [23] that also co-localizes with peri-nuclear
protein aggregates, aggresomes [26,27]. It is involved in both
aggresome formation (aggregate formase) as well as clearance of
protein aggregates (unfoldase) based on the concentration of
aggregation prone-proteins [28]. Since aging is associated with the
accumulation of protein aggregates [21,22], we anticipate that
selective inhibition of VCP’s aggresome formation function may
regress the age-related patho-physiological conditions. Moreover,
VCP overexpression is also related to cancer [29,30], inflamma-
tion and NFkB activation [31,32]. The contribution of VCP to
age-related changes in proteostasis and inflammation is although
obvious but scarcely investigated. Although decline of proteasomal
activity is known to be associated with the age-related disorders
but the role of VCP and early events involved in this process are
not apparent. To address this, we designed this study to identify
the early-age-related (pediatric vs. adult) proteostasis mechanisms
that augment NFkB mediated inflammation. In addition to
focusing on constitutive early-age-related changes, we used both
cecal ligation and puncture (CLP) mediated sepsis and Pseudomonas
aeruginosa (Pa)-lipopolysacharride (Pa-LPS) induced acute lung
injury (ALI) models to verify if these early-age-related changes
aggravate the inflammatory pathophysiology.
Sepsis or septic shock is the major risk factor for mortality in the
aged population [33]. The mortality rate in the CLP induced septic
shock murine model is higher in the older mice [34], owing to a
more severe and fatal systemic injury. A recent study by Isaiah R.
Turnbull et al [35] demonstrates that when injury (CLP) is kept
constant, the aged mice develop a more severe inflammatory
response that results in higher mortality rates. In contrast, when
aged mice receive a less severe injury, they still develop a similar
inflammatory response that is comparable to the young mice
receivingamoresevereinjury.Thesestudiessuggested thatanimal’s
immunopathologicalresponsetosepsisdetermines mortalityinaged
animals as compared to the young when subjected to similar injury
levels but were unable to identify the mechanism for aberrant
immune-stress response. Similarly, in Pa-LPS induced ALI murine
model advancing age is related to an increased pulmonary
inflammatory insult [36] and plasma MPO levels. Our study
demonstrates the critical role of proteostasis-imbalance as an early
age-related change that may be further exacerbated with aging. We
found that adult mice are more susceptible to sepsis and ALI as
compared to the pediatric group and predict that this may worsen
with advancing age resulting in chronic- or fatal- injury.
Materials and Methods
Ethics Statement
All animal experiments were carried out in accordance with the
Johns Hopkins University (JHU) Animal Care and Use Committee
(ACUC) approved protocols.
Reagents and treatments
The HBE cells were cultured at 37uC with 5% CO2 in MEM
media supplemented with 10% Fetal Bovine Serum (FBS) and 1%
Penicillin, Streptomycin and Amphotericin B (PSA) from Invitro-
gen. Number of apoptotic cells in longitudinal lung sections of
pediatric and adult mice pre- and post- Pseudomonas aeruginosa LPS
(Pa-LPS, Sigma)/CLP treatments were quantified by Dead End
TM
Fluorogenic TUNEL system (Promega). For in vitro experiments,
cells were treated with 1 mM MG-132 (Calbiochem) and/or
50 mM Salubrinal (Tocris Bioscience) for indicated time points.
Pediatric and adult mice were treated by intratracheal (i.t.)
instillation with 1 mg/gm body weight Pa-LPS in 100ml total
volume of PBS or underwent cecal ligation and puncture (CLP)
surgery followed by intra-peritoneal (i.p) treatment with Salubrinal
(1 mg/kg body weight). For controls, i.t. mice were compared to
100 ml PBS and CLP group to sham.
Murine experiments
The weight and sex matched 3 weeks-pediatric and 6 months-
adult group (representing young pediatric and 25-year old adult
human subjects) of C57BL/6 mice (NCI Animal Production
Program) were used to identify early-age- related changes. Mice
were housed in controlled environment and pathogen-free
conditions. We induced lung injury in these mice by i.t instillation
of Pa-LPS (1mg/gm bw, in 100 ml PBS) for 24 hours that resulted
in approximately 1–1.5 g loss in body weight. The mice were
sacrificed after 24 hours of either Pa-LPS treatment or CLP (cecal
ligation and puncture, described below) surgery and the lungs were
harvested in T-PER tissue lysis buffer (Thermo Scientific)
supplemented with protease inhibitor cocktail (Sigma) while
bronchoalveolar lavage fluid (BALF, isolated using 1 ml PBS)
was isolated for IL-6 quantification by standard sandwich ELISA
(eBiosciences) following manufacturer’s instructions. The serum
was also harvested from these mice for quantification of IL-6 (as
above) and neutrophil activity using the mouse MPO kit (Hycult
Biotechnology) as we previously described [37]. The peritoneal
cavity of the mice from CLP group was flushed with 10 ml PBS to
isolate peritoneal lavage cells for flow cytometry (described below).
Cecal ligation and puncture (CLP) surgery
CLP is the most widely used model for experimental
polymicrobial sepsis in mice, the procedure was performed as
described before [38]. Briefly, mice were anesthetized by 0.1 ml
i.p. injection containing ketamine (100 mg/kg) and xylazine
(10 mg/kg) in PBS [38]. A midline laparotomy was performed
and the cecum was located. The distal 50% of exposed cecum was
ligated with 3-0 silk suture and punctured with 1 through and
through pass of a 20-gauge needle. The cecum was replaced in the
abdomen, and the incision was closed with 3-0 suture. Postoper-
atively, the animals were resuscitated with 1 ml subcutaneous
injection of sterile 0.9% NaCl. After 2 hours of CLP, some groups
of mice received a single i.p injection of Salubrinal (1 mg/kg body
weight).
In vitro experiments
The HBE cells were treated with MG-132 (1 mM) for 2 hours or
overnight. The media was removed and the cells were washed
once with sterile PBS. The cells were starved for 30 minutes in
methionine-cysteine-free media (MP Biomedicals) followed by
pulse with 250 mCi
35S labeled methionine-cysteine for indicated
time points. The cells were washed in 16PBS after the indicated
time points (pulse) and harvested in M-PER cell lysis buffer
(Pierce) supplemented with protease inhibitor cocktail. The total
Proteostasis-Imbalance in Sepsis and ALI
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(described below) followed by detection of newly synthesized and
metabolically labeled ubiquitin and ubiquitinated proteins by
autoradiography [39]. In another experiment, the cells were
treated with MG-132 (1 mM) and Salubrinal alone or in
combination for 24 hours. Total protein lysates were isolated
from cells as described above and changes in levels of
ubiquitinated proteins were quantified by immunoblotting.
Immunoblotting and immunoprecipitation
The mouse lungs from pediatric and adult mice were sonicated
(4–56, 10 sec pulses) in the T-PER tissue lysis buffer or cells were
lysed in M-PER, supplemented with protease inhibitor cocktail,
centrifuged at 13,000 rpm24uC for 10 min and the supernatants
were collected as total protein lysates. The total protein lysates
were immunoblotted for the following antibodies from Santa Cruz
Biotechnology (scbt): Ubiquitin (Ub, mouse monoclonal), VCP
(rabbit polyclonal), NFkB (rabbit polyclonal), p-eIF2a (rabbit
polyclonal), PSMB6 (mouse monoclonal). The anti-b-actin
antibody (mouse monoclonal, Sigma) was used as the loading
control. The primary antibodies binding was quantified using anti-
rabbit or mouse IgG HRP secondary antibodies (Amersham) and
Super Signal West Pico Chemiluminescent Substrate kit (Pierce).
To evaluate the aggregation of ubiquitinated proteins, we collected
the insoluble protein fractions (pellets) by high speed centrifugation
(12,000 rpm for 10 mins) of equal amount (500mg) of total protein
lysates isolated from pediatric- and adult- murine lungs. These
pellets were re-suspended in loading dye containing b-mercapto-
ethanol (Invitrogen) and run on SDS-PAGE (10%) followed by
immunoblotting for Ub and b-actin. For immunoprecipitation
experiment, the total protein lysate was used to immunoprecipitate
ubiquitin or ubiquitinated proteins using the mouse monoclonal
Ub antibody (1 mg, scbt) and protein A/G agarose beads (scbt) as
described before [40]. The agarose-ubiquitin conjugate was
dissolved in the loading dye containing b-mercaptoethanol and
run on SDS-PAGE followed by autoradiography of dried gel
(Drygel Sr., Hoefer Scientific Instruments, San Francisco, 80uC for
2 hours) to quantify the changes in metabolically labeled
ubiquitinated proteins.
Immunofluorescence microscopy, TUNEL assay and flow
cytometry
The longitudinal tissue sections from murine lungs were
immunostained with the primary antibodies (1:50 to 1:200
dilution) for Ub (mouse monoclonal, scbt), NFkB (rabbit
polyclonal,scbt) and VCP (rabbit polyclonal, scbt) followed by
the secondary antibodies (1:200 dilution), using our previously
described protocol [37]. The secondary antibodies used were goat
anti-rabbit IgG FITC (scbt), donkey anti-mouse Dylight 594
(Jackson ImmunoResearch). Nuclei were detected by Hoechst
(Invitrogen) staining while H&E was used to evaluate lung
morphology and inflammatory state. The number of apoptotic
cells was quantified by Dead End
TM Fluorogenic TUNEL system
(Promega) using our previously standardized method [41]. Images
were captured by Axiovert 200 Carl Zeiss Fluorescence micro-
scope using the Zeiss Axiocam HRC camera and Axiovision
software. All fluorescent images were captured at room temper-
ature with air (206 and 406, fluorescence) as the imaging
medium. The magnifications for fluorescence microscope were LD
Plan- Achroplan (206/0.40 Korr Phz) and Neo Fluar (406/0.66
Phz Korr) with 1.66optivar. For flow cytometry based analysis,
peritoneal lavage cells were subjected to red blood cell lysis using
the ACK lysis buffer (Quality Biologicals) followed by 16 PBS
wash. The cells were blocked with appropriate sera (goat or
donkey) and stained with CD4 (PE-conjugated, rat monoclonal,
scbt), Mac-3, (rat monoclonal, Abcam) and NIMP R-14 (rat
monoclonal, Abcam) followed by the anti-rat PE labeled
secondary antibody. The FIX & PERMHCELL PERMEABILI-
ZATION kit (Invitrogen) was used for intracellular IFNc-FITC
(rat polyclonal, Invitrogen) staining. The stained cells were washed
2-times in FACS buffer and resuspended in 0.1 % paraformalde-
hyde (USB Corporation). The data was acquired using the BD
FACS Caliber instrument and analyzed using the BD Cell Quest
software.
Statistical analysis
Data is represented as the mean 6 SEM of at least three
experiments, and Student’s t test and ANOVA were used to
determine the statistical significance. The murine microscopy data
was analyzed by densitometry (Matlab R2009b, Mathworks Co.)
followed spearman’s correlation coefficient analysis to calculate the
significance among the indicated groups.
Results
Early-age-related changes in the proinflammatory
response of murine lungs
To evaluate and identify the early-age-related changes that may
augment the immunopathogenesis of sepsis or acute lung injury,
we compared 3-week (pediatric) to 6-month (adult) old mice
group. We observed a significant (p,0.03) constitutive increase in
interleukin-6 (IL-6) levels in both serum and bronchoalveolar
lavage fluid (BALF) of adult mice as compared to the pediatric
(Fig. 1A, B). Next, we verified the early-age-related changes in
activity of neutrophil marker, myeloperoxidase (MPO) based on
the recent reports demonstrating the higher MPO activity in the
serum of elderly humans [42] and rat kidney’s [43]. Our data
shows a significant increase in constitutive and Pa-LPS induced
serum-MPO activity (n=3, Fig. 1C, p,0.05) in the adult mice as
compared to the pediatric. We did not observe a similar increase
in adult-mice MPO levels after CLP, as compared to the pediatric,
although it shows a trend towards an increase. Our data indicate
that both IL-6 and MPO activity are constitutively elevated in
adult mice as an early-age-related change.
Early-age-related proteostasis-imbalance augments
constitutive NFkB levels
To identify the early-age-related changes involved in proteos-
tasis- and inflammatory- imbalance, we used well characterized
models of acute lung (intra-tracheal, i.t, Pa-LPS instillation) and
systemic (cecal ligation and puncture, CLP) [35,36] inflammation.
We found a significant constitutive increase in accumulation of
ubiquitinated proteins (Ub) in the adult as compared to the
pediatric mice lungs that correlate with higher NFkB and p-eIF2a
levels (Fig. 2A, top panel). Moreover, we observed that these
changes are amplified in Pa-LPS treated adult mice compared to
the pediatric. We also observed a correlative significant increase in
VCP protein levels in Pa-LPS treated adult mice compared to the
pediatric (Fig. 2A, top and bottom panels). The induction of VCP
expression in chronic inflammatory states like cancer [29], cystic
fibrosis [39] and neurodegenerative conditions [44] results in
proteostasis-imbalance and pathogenesis of disease. As demon-
strated previously for other proteasome subunits [45], we observed
a decreased PSMB6 expression in the adult mice lungs compared
to the pediatric group (Fig. 2A, top panel) indicative of early-age-
related proteostasis-imbalance. We also observed a constitutive
change in accumulation of ubiquitinated proteins and VCP
expression in the liver of adult mice compared to the pediatric
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aggregation of misfolded- or damaged- proteins is a characteristic
of age-related pathogenic conditions [17]. To confirm an early-
age-related proteostasis-imbalance we immunoblotted the insolu-
ble protein fractions (pellets) of adult- and pediatric- lung total
protein lysates for Ub. Interestingly, the lungs of the older mice
have significantly higher levels of ubiquitinated proteins in the
soluble fraction (Fig. 2A) as compared to the insoluble (Fig. 2C)
indicating accumulation of ubiquitinated proteins in endoplasmic
reticulum (ER). In contrast, the liver has most of the ubiquitinated
proteins in the insoluble form (aggregates) (Fig. 2D) and not in the
soluble fraction (Fig. 2B) suggesting cytosolic aggregation of
ubiquitinated proteins (aggresomes). It is possible that liver has
higher VCP induction (Fig. 2B, bottom panel) that may lead to
aggresome formation, whereas the relatively lower increase in
VCP protein levels in lungs may be a response to accumulation of
ubiquitinated-proteins in ER as verified by increase in p-eIF2a.
Age-related proteostasis-imbalance augments
inflammation and apoptosis
The apoptosis of various cell types is known as a critical
mediator for pathogenesis of COPD [46], acute lung injury (ALI)
Figure 1. Early-age-related constitutive increase in IL-6 levels and MPO activity. (A, B) The constitutive significant (p=0.027, 0.029)
increase in IL-6 levels in the serum and bronchoalveolar lavage fluid (BALF) of the adult (6-month) mice compared to the pediatric (3-weeks) shows an
early-age-related change in pro-inflammatory immune response. (C) To confirm if intrinsic change in proinflammatory response is an early-age-
related event, myeloperoxidase (MPO) activities in serum samples of pediatric- and adult- control (PBS), Pa-LPS and CLP, mice were quantified. We
found an early-age-related increase in constitutive and Pa-LPS induced MPO activity in the adult mice as compared to the pediatric (p values: *** Ped
Control vs. Adult Control = 0.0000139; ** Ped Pa-LPS vs. Adult Pa-LPS = 0.045). The data is shown as mean 6 SEM of n=3–4 mice in each group. The
early-age-related changes in the pro-inflammatory response contribute to the immunopathogenesis of sepsis and ALI.
doi:10.1371/journal.pone.0015480.g001
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augmentation of apoptotic cell death in ALI and COPD [46,47].
We demonstrate here a significant increase in lung cell apoptosis
(TUNEL, Fig. 3A) in the adult mice as compared to the pediatric
that was further enhanced by Pa-LPS or CLP. The H&E staining
of lung sections from control, Pa-LPS or CLP mice verify an age-
related increase in inflammatory lung phenotype of adult mice as
compared to the pediatric (Fig. 3B). Immunofluorescence staining
for NFkB and VCP (Fig. 3C & D, left panel) in murine lungs
substantiates the immunoblotting data (Fig. 2A). This significant
increase (p,0.001) in constitutive as well as Pa-LPS or CLP
induced NFkB and VCP protein levels (Fig. 3C & D, left panel) in
the adult as compared to the pediatric mice also correlates with the
ubiquitin accumulation (p,0.001, Fig. 3E, left panel). The
statistical analysis of the data, Fig. 3C, D and E is shown in the
right panel. Overall, the data verifies that proteostasis-imbalance is
Figure 2. Early-age-related changes in proteostasis induce inflammation. The total protein lung- (A) and liver- (B) lysates from control, CLP
or i.t. (1 mg/gm bw) Pa-LPS induced murine model (n=3) were immunoblotted for Ub (ubiquitin), PSMB6 (proteasome-subunit), VCP (UPR), NFkB
(Inflammation), p-eIF2a (protective stress response) and b-actin. (A) The adult mice lungs show constitutive increase in NFkB and p-eIF2a levels and
accumulation of ubiquitinated-proteins while levels of proteasomal subunit, PSMB6 decrease. The Pa-LPS further induces the levels of these proteins
and VCP in adult mice while PSMB6 is lower indicating that proteostasis-imbalance in adult subjects is a critical early-age-related change that may
induce immunopathogenesis of chronic- of fatal- injury in older subjects. (B) The liver shows a constitutive increase in VCP expression in the adult
mice which correlates with higher accumulation of ubiquitinated proteins. The bottom panel (A & B) shows the densitometric analysis of VCP
expression in both lung and liver normalized to b-actin (Mean 6 SEM, n=3, *p,0.05). (C&D ) Of note here, both lung (C) and liver (D) also show
accumulation of ubiquitinated-proteins in the insoluble protein fraction of adult mice as compared to the pediatric (n=3) but lungs have relatively
less accumulation of ubiquitinated proteins in insoluble fraction as compared to the liver. The early-age-related proteostasis-imbalance induces NFkB
mediated inflammatory response.
doi:10.1371/journal.pone.0015480.g002
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The longitudinal lungs sections from control, CLP or i.t. Pa-LPS (1 mg/gm bw) induced murine model (n=3–4) were processed for histological
evaluation. (A) We verified by TUNEL assay that accumulation of damaged- or misfolded- proteins leads to an increase in lung cell apoptosis in the
adult mice by quantifying the changes in number of TUNEL positive cells. This is further exacerbated by Pa-LPS- or CLP- induced injury, verifying the
correlation of ubiquitinated protein accumulation to increased apoptosis. The bottom panel of each staining shows the spearman’s correlation
coefficient analysis of the number of apoptotic cells in pediatric- and adult- mice (10 uniform representative areas from each mouse). (B) The adult
mice show a constitutive increase in inflammation as compared to the pediatric group (H&E) that correlates with an increase in NFkB (C) and VCP (D)
protein levels. The right panel of each staining shows the spearman’s correlation coefficient analysis of fluorescence intensity in pediatric- and adult-
mice (10 uniform representative areas from each mouse). (E) The Pa-LPS and CLP treatments induce the accumulation of ubiquitinated proteins that
correlates with further increase in protein levels of NFkB (C) and VCP (D). Data confirms that early-age-related proteostasis-imbalance augments Pa-LPS
or sepsis induced injury.
doi:10.1371/journal.pone.0015480.g003
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endotoxin (Pa-LPS) or sepsis (CLP) mediated inflammatory insults.
We anticipate that this may further exacerbate with aging.
Salubrinal inhibits accumulation of ubiquitinated
proteins and NFkB levels
In order to mimic the aging microenvironment in vitro,w e
treated HBE cells with a low dose of MG-132 (1 mM) for either
2 hours or overnight to read out the effect of lower proteasomal
activity on protein turnover rates. We used the metabolic labeling
and ubiquitin immunoprecipitation to ‘chase’ the synthesis and
accumulation of ubiquitinated proteins. The data shows that
overnight treatment with low dose MG-132 diminishes the
synthesis of ubiquitinated proteins as compared to the shorter
2 h treatment (Fig. 4). We anticipate that this is a feedback
regulatory mechanism to counteract accumulation of ubiquiti-
nated proteins triggered by proteasome inhibition. The data
indicate that age-related decrease in proteasomal activity impacts
protein turnover rates.
To standardize the therapeutic strategy for controlling the
pathophysiology of age-related proteostasis-imbalance, we in-
duced substantial accumulation of ubiquitinated proteins in HBE
cells by treating them with 1 mM MG-132 for 24 hours as
detected by immunostaining (Fig. 5A). Since accumulation of
ubiquitinated-proteins triggers an ER stress response [18], we
controlled the MG-132 induced accumulation of ubiquitinated-
proteins by treating these cells with 50 mM salubrinal, a known
selective inhibitor of cellular phosphatase complexes that de-
phosphorylate eIF2a [49], to clear off protein-aggregation. We
verified that salubrinal reduced MG-132 induced ubiquitinated-
protein accumulation. Statistical analysis of microscopy data
(Fig. 5A, bottom panel) verifies that salubrinal is capable of
significantly (p=0.001) reducing the MG-132 induced ubiquiti-
nated-protein accumulation in addition to protecting cells from
ER stress, by interfering with protein folding and/or processing
pathways. We confirmed this data by western blotting of total
protein lysates from HBE cells treated with the same doses of
MG-132 and salubrinal (Fig. 5B). We verified that salubrinal is
able to control the NFkB induction (Fig. 5B) as anticipated. Since
MG-132 treatment may inhibit the degradation of IkBd i r e c t l y ,
we did not observe a significant induction of NFkB (Fig. 5B, lane
2) in MG-132 treated cells in spite of ubiquitin accumulation.
Our data indicate the therapeutic potential of salubrinal in
Figure 4. Proteasome inhibition regulates protein turnover
rates. The human bronchial epithelial cells (HBE) were treated for
2 hours (2 h, partial) or overnight (O/N, broad) with low dose
proteasome inhibitor (MG-132, 1 mM) and accumulation of newly
synthesized ubiquitinated protein was monitored over time by
metabolic labeling and immunoprecipitation. Lower levels of ubiquiti-
nated proteins in overnight MG132 treated cells during protein
synthesis indicate that decreased proteasomal activity inhibits protein
synthesis as a feedback inhibition loop. Lower proteasomal activity
inhibits protein turnover rates (proteostasis-imbalance) by inhibiting both
protein- synthesis and degradation.
doi:10.1371/journal.pone.0015480.g004
Figure 5. Salubrinal corrects proteostasis-imbalance by inhib-
iting the accumulation of ubiquitinated proteins. (A) The HBE
cells were treated with MG-132 (1 mM) for 2 hours followed by
treatment with (salubrinal, 50 mM) for another 22 hours and accumu-
lation of ubiquitinated proteins was detected by Ub-immunostaining.
The bottom panel shows the spearman’s correlation coefficient analysis
of fluorescence intensity. Data (n=4) indicate a significant reduction in
MG-132 induced ubiquitinated-protein accumulation by salubrinal,
indicating its potential therapeutic use in treating age-related
proteostasis-imbalance. (B) The HBE cells were treated with MG-132
and/or salubrinal (as in A) and the total protein lysates were
immunoblotted for Ub, NFkB and b-actin. Data shows that salubrinal
controls ubiquitin accumulation and NFkB induction. Salubrinal may be
effective in controlling age-related proteostasis-imbalance and inflamma-
tory response.
doi:10.1371/journal.pone.0015480.g005
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of sepsis and age-related disorders.
Therapeutic efficacy of proteostasis-regulators in adult
murine model of sepsis
The chronic and fatal inflammatory diseases are known to have
a more severe outcome with advancing age [11]. An age-
dependent increase in ER stress, in wistar rats involves reduced
phosphorylation of eIF2a [50]. Hence, we tested the efficacy of
salubrinal as an inducer of eIF2a phosphorylation on CLP
induced IL-6 secretion and infiltration of pro-inflammatory cells in
the adult mice. We found that salubrinal significantly reduces
(p=0.05) CLP induced IL-6 levels in the peritoneal lavage (Fig. 6A)
of adult mice. Salubrinal also controls the number of peritoneal
pro-inflammatory cells (neutrophils and macrophages) in CLP
induced sepsis (C57BL/6 mice, n=3) (Fig. 6B). A decrease in CLP
induced CD4
+ T cells is previously reported [51], and our data
shows that salubrinal is able to restore the decreased number of
CD4
+ T cells. Our in vivo (Fig. 6) and in vitro (Fig. 5A & B) data
suggests that salubrinal can not only reduce ubiquitin-accumula-
tion but may also control the pro-inflammatory response in injury
related infection to avoid the immunopathogenesis of chronic or
fatal disease in older subjects. Our data warrants further
preclinical evaluation of salubrinal in 24-month old mice and
Fisher 344 rat aging model (NIA, NIH) based on its ability to
control proteostasis-imbalance.
Discussion
The outcome of any systemic injury is the culmination of
genetic, environmental and physiological factors, and all these
factors are modulated with increasing age of an organism. We
demonstrate that an early-age-related proteostasis-imbalance
aggravates the outcome of severe injury which may result in an
increased risk of death. A less age difference in the mice for this
study was deliberately used to compare and identify the early
changes in proteasome mediated protein processing and its
outcome on systemic or lung injury with the onset of the aging
process. We also demonstrate here the therapeutic potential of
salubrinal for treating age-related disorders based on its ability to
control MG-132 or CLP induced ubiquitin accumulation, ER
stress and NFkB mediated inflammation, the major contributors of
age-related pathological conditions.
The age-related decline in proteasome activity is well docu-
mented [1], although studies relating its influence on the outcome
of severe injury (sepsis/LPS) are scarce [35]. Our data suggest that
early-age-related intrinsic proteostasis-imbalance may contribute
to the constitutive pro-inflammatory condition [52], Fig. 1A, B)]
that can be further exacerbated with infection and/or injury. An
early-age-related increase in both constitutive as well as Pa-LPS
induced neutrophil activity marker, MPO (Fig. 1C) substantiates
this conclusion and indicate the critical role of neutrophils in the
immunopathogenesis of age-related disorders [11]. The age-
related increased in NFkB activity is due to the hyper-
phosphorylation of its endogenous inhibitor, IkB, resulting in its
retrograde translocation for proteasomal degradation by the
valosin-containing protein (VCP) [23]. Our data indicate that
VCP activity is higher in the lungs (Pa-LPS induced) and liver
(constitutive and CLP induced) of adult mice compared to the
pediatric as an early-age-related (Fig. 2A, B and Fig. 3D) event
that may contribute to the intrinsic as well as Pa-LPS/CLP
mediated inflammatory signaling, NFkB activity, ER stress and
apoptosis. The age-related accumulation of misfolded or damaged
proteins in the endoplasmic reticulum (ER) induces apoptosis due
to ER stress response [18] while cytosolic aggregation (aggresome)
may induce autophagy and apoptosis by ER-independent
mechanisms [23]. The ER is a major site of posttranslational
protein processing. Equilibrium between the flux of misfolded or
damaged proteins entering the ER and the capacity of the
organelle to handle its load is maintained by several signaling
pathways that together trigger the unfolded protein response
(UPR). UPR is initiated in response to an imbalance between
protein folding and breakdown capacity or extent of protein
overload, a condition leading to ER stress. We demonstrate here
that constitutive and Pa-LPS induced p-eIF2a levels are up-
regulated in the lungs of adult mice (Fig. 2A) as an early marker of
proteostasis-imbalance. The increase in p-eIF2a is triggered as a
protective stress response to accumulation of ubiquitinated-
protein. The p-eIF2a inhibits the overall protein synthesis [53]
as a mechanism to combat the accumulation of ubiquitinated-
proteins. Similarly, the expression of UPR modifier and
proteostasis-regulator, VCP is trigged to control the accumulation
of ubiquitinated-proteins. In addition to its UPR modifier
function, VCP is a major component of ER-associated protein
degradation (ERAD) machinery that is involved in retrograde
translocation of misfolded- or damaged- proteins for cytosolic
proteasomal degradation [54]. Although VCP levels may be
elevated in adults as an protective mechanism to induce the
clearance of aggregated proteins [23,26], it also induces inflam-
mation and apoptosis by mediating the degradation of IkB, an
endogenous inhibitor of NFkB. Moreover, age-related changes in
VCP levels are known to induce chronic inflammation, patho-
genesis of neurodegenerative diseases and cataract [11,55,56,57].
Interestingly, VCP expression is described as a biomarker of
Alzheimer’s disease [58] which is also an age-related disease
[59].
Next, we used proteasome inhibitor- MG-132 treatment of
HBE cells as an in vitro model to identify that lower proteasomal
activity restrain protein turnover rates by inhibiting both protein
degradation and synthesis. We identified that overnight incubation
of HBE cells with 1 mM MG-132 hampers protein synthesis (Fig. 4)
in addition to the accumulation of ubiquitinated proteins (Fig. 5A).
This data implies that proteasome inhibition triggers a feedback
mechanism by reducing protein synthesis to decrease the load on
the proteasome degradation machinery. A similar compensatory
mechanism may operate as an early age-related process, where an
intrinsic decrease in proteasome activity may diminish protein
synthesis, partially restoring the proteostasis imbalance in the
organism. Nevertheless, a gradual decrease in the proteasome
activity with aging reaches a scenario where this homeostatic
mechanism is abrogated leading to various age-related disease
conditions. We also used the in vitro model (described above) to
verify the therapeutic efficacy of salubrinal (a selective inhibitor of
eIF2a de-phosphorylation) in controlling protein folding and
processing based on its ability to reduce the accumulation of
ubiquitinated proteins. The accumulation of ubiquitinated pro-
teins by MG-132 treatment was cleared-off by co-treatment with
salubrinal (Fig. 5A, B), which is known to protect cells from UPR
by up-regulating and maintaining the levels of p-eIF2a [49]. We
anticipate that salubrinal not only inhibits protein synthesis but
allows the degradation of aggregated proteins via the ubiquitin-
proteasome system [60]; a strategy which would be beneficial in
the adults and vital for older subjects, where proteasome activity is
diminished. Moreover, salubrinal treatment was also able to
control the NFkB induction (Fig. 5B). Our data and previous
studies [61] suggest that salubrinal controls NFkB mediated
inflammatory response by 1) inducing UPR and 2) inhibiting
ubiquitin accumulation.
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PLoS ONE | www.plosone.org 8 November 2010 | Volume 5 | Issue 11 | e15480Figure 6. Salubrinal controls CLP induced inflammatory response. The peritoneal lavage from age- and sex- matched control, CLP and/or
intraperitoneal (i.p.) salubrinal (1 mg/kg/bw) groups of C57BL6 mice (n=3–4) were used to quantify changes in IL-6 (A) levels, and number and pro-
inflammatory state of inflammatory cells (B). (A) Salubrinal is effective in significantly (p=0.05) controlling the CLP induced pro-inflammatory
cytokine, IL-6 levels. (B) The flow cytometry analysis shows the number (x-axis) of peritoneal neutrophils (NIMP-R14), macrophages (Mac3) and CD4+
T cells (CD4) isolated from control- and CLP- groups after 24 hrs, with- and without- salubrinal treatment. The pro-inflammatory state of individual cell
population was verified by co-staining for intracellular IFNc (y-axis). Data shows increase in numbers of neutrophils (upper panel) and macrophages
(middle panel) with decreasing IFNc levels after CLP while number of CD4
+ T cells (lower panel) decrease and have increased IFNc levels. Salubrinal is
effective in controlling CLP induced inflammatory response.
doi:10.1371/journal.pone.0015480.g006
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PLoS ONE | www.plosone.org 9 November 2010 | Volume 5 | Issue 11 | e15480We verify here the therapeutic efficacy of salubrinal to control
CLP induced pro-inflammatory cytokine (IL-6) secretion (Fig. 6A).
We also demonstrate here that CLP induced infiltration of pro-
inflammatory cells in adult murine model of sepsis is controlled by
salubrinal (Fig. 6B). Our data suggest that salubrinal may be a
useful drug candidate for treating sepsis or ALI in older subjects
based on its ability to clear accumulation of ubiquitinated protein
and ER stress caused by reduced proteasomal activity. The studies
by Isaiah R. Turnbull et al indicate that the increased local
immune response to sepsis with age is the outcome of a
fundamental age-based difference. Our data demonstrates that
decrease in proteasomal activity with increased VCP-retrograde
translocation activity is an early-age-related change that initiates
the accumulation of ubiquitinated proteins inducing NFkB levels,
ER stress and apoptosis. Although initial induction of VCP is a
cytoprotective response but its prolonged induction in older
subjects with decreased proteasomal activity may result in a
chronic or fatal injury by chronic NFkB activation and apoptosis.
In conclusion, our findings show that an intrinsic deregulation
of proteostasis is an early-age-related event that modulates the
inflammatory response to Pa-LPS/CLP induced injury. We
propose salubrinal as a modulator of early-age-related proteos-
tasis-imbalance and its use as a therapeutic strategy to control
chronic or fatal injury in the older subjects (Fig. 7). The study
warrants further investigation in an appropriate preclinical aging
murine- and rat- models as well as young- and old- human
subjects.
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